What is the risk of developing gallstone disease in a 42-year-old white male with a Body Mass Index (BMI) of 29?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gallstone Disease Risk in a 42-Year-Old White Male with BMI 29

In a 42-year-old white male with BMI 29, the risk of gallstone disease is approximately 10-15%, which is lower than the general population average due to male sex but elevated by the overweight BMI status. 1, 2

Baseline Population Risk

  • In white adults from developed countries, the overall prevalence of gallstones ranges from 10-15%, with approximately 20% of adults developing gallstones over their lifetime. 3, 2
  • Male sex significantly reduces gallstone risk compared to females, with men having roughly half the prevalence of women across all age groups (9.5% in men versus 18.8% in women in European populations). 4

Age-Specific Considerations

  • At age 42, this patient is in a moderate-risk age category, as gallstone prevalence increases progressively with age. 4, 5
  • By age 50, approximately 10-15% of men will have developed gallstones, and this increases to 15% by age 70 and 20% by age 75. 4, 5
  • The patient's current age places him below the peak prevalence years but within the range where gallstone formation begins to accelerate. 4

Impact of Overweight Status (BMI 29)

  • Elevated BMI is a causal risk factor for symptomatic gallstone disease, with genetic evidence supporting this relationship particularly in women but also present in men. 6
  • Obesity and overnutrition are established modifiable risk factors that increase gallstone risk through mechanisms related to metabolic syndrome. 3, 2
  • For each 1 kg/m² increase in BMI, the risk of symptomatic gallstone disease increases by approximately 4-7% in observational studies. 6
  • With a BMI of 29 (overweight category, approaching obesity threshold of 30), this patient has an elevated risk compared to normal-weight males, though the effect is less pronounced than in women. 6

Clinical Implications

  • Approximately 80% of gallstones remain asymptomatic throughout life, with only 1-4% of patients with gallstones developing symptoms annually. 4, 7
  • If gallstones do develop, the likelihood of remaining asymptomatic is high, and expectant management is the standard approach for asymptomatic stones. 8, 7
  • The patient's modifiable risk factor (overweight status) presents an opportunity for primary prevention through lifestyle modifications including weight management and increased physical activity. 3

Risk Stratification Summary

  • This patient's overall risk is moderate: lower than average due to male sex, but elevated above baseline for males due to overweight status. 4, 6
  • His risk will continue to increase with age, particularly if BMI increases further or if he develops additional metabolic syndrome components. 3, 2

References

Research

Gallstone Disease: Common Questions and Answers.

American family physician, 2024

Research

Epidemiology of gallstones.

Gastroenterology clinics of North America, 2010

Research

Gallstones.

Nature reviews. Disease primers, 2016

Guideline

Gallstone Formation and Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Epidemiology and natural history of gallstone disease.

Gastroenterology clinics of North America, 1991

Guideline

Asymptomatic and Symptomatic Gallstone Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Formation of Bile Stones (Cholelithiasis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.